Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Guillon

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Pharmacological and Toxicological Methods|April 19, 2012
How do the top 12 pharmaceutical companies operate safety pharmacology?Lorna Ewart, David J Gallacher, Gary Gintant, et al.
European Journal of Ophthalmology|October 30, 2016
Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiencyChristophe Baudouin, David J Galarreta, Ewa Mrukwa-Kominek, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2020
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated ComorbiditiesMarie-Laure Ozoux, Véronique Briand, Michel Pelat, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|August 4, 2024
BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapiesShehzad A Naroo, Craig A Woods, Raquel Gil-Cazorla, et al.
Journal of Pharmacological and Toxicological Methods|April 7, 2015
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortiumBrian D Guth, Alan Y Chiang, Jennifer Doyle, et al.
Journal of Pharmacological and Toxicological Methods|January 10, 2017
An evaluation of the utility of LVdP/dt<sub>40</sub>, QA interval, LVdP/dt<sub>min</sub> and Tau as indicators of drug-induced changes in contractility and lusitropy in dogsMichael K Pugsley, Brian Guth, Alan Y Chiang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 3, 2018
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot StudyDaniel Millard, Qianyu Dang, Hong Shi, et al.
International Journal of Toxicology|December 21, 2018
A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored ConsortiumEmmanuel Boulay, Matthew M Abernathy, Ray Chui, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2021
SAR340835, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart FailureMichel Pelat, Fabrice Barbe, Cyril Daveu, et al.
Toxicology and Applied Pharmacology|June 5, 2013
Safety pharmacology--current and emerging conceptsJunnat Hamdam, Swaminathan Sethu, Trevor Smith, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Pharmacological and Toxicological Methods|April 19, 2012
How do the top 12 pharmaceutical companies operate safety pharmacology?Lorna Ewart, David J Gallacher, Gary Gintant, et al.
European Journal of Ophthalmology|October 30, 2016
Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiencyChristophe Baudouin, David J Galarreta, Ewa Mrukwa-Kominek, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2020
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated ComorbiditiesMarie-Laure Ozoux, Véronique Briand, Michel Pelat, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|August 4, 2024
BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapiesShehzad A Naroo, Craig A Woods, Raquel Gil-Cazorla, et al.
Journal of Pharmacological and Toxicological Methods|April 7, 2015
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortiumBrian D Guth, Alan Y Chiang, Jennifer Doyle, et al.
Journal of Pharmacological and Toxicological Methods|January 10, 2017
An evaluation of the utility of LVdP/dt<sub>40</sub>, QA interval, LVdP/dt<sub>min</sub> and Tau as indicators of drug-induced changes in contractility and lusitropy in dogsMichael K Pugsley, Brian Guth, Alan Y Chiang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 3, 2018
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot StudyDaniel Millard, Qianyu Dang, Hong Shi, et al.
International Journal of Toxicology|December 21, 2018
A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored ConsortiumEmmanuel Boulay, Matthew M Abernathy, Ray Chui, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2021
SAR340835, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart FailureMichel Pelat, Fabrice Barbe, Cyril Daveu, et al.
Toxicology and Applied Pharmacology|June 5, 2013
Safety pharmacology--current and emerging conceptsJunnat Hamdam, Swaminathan Sethu, Trevor Smith, et al.
Pageof 8